Tricyclic fused pryimidine derivatives, and their use as pharmac

Details Tricyclic fused pryimidine derivatives, and their use as pharmac Tricyclic fused pryimidine derivatives, and their use as pharmac

1988-08-16

1990-03-27

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514267, 540498, 540548, 544251, A61K 31505, C07D48714

Patent

active

049121049

ABSTRACT:
Novel tricyclic fused pyrimidine derivatives represented by the formula (I): ##STR1## wherein R.sup.1 and R.sup.2 are independently C.sub.1-8 alkyl or C.sub.2-8 alkenyl;

REFERENCES:
patent: 3637684 (1972-06-01), Goldman
patent: 3810894 (1974-05-01), Kranz et al.
patent: 4603203 (1986-07-01), Furukawa et al.
Golec, et al., Chemical Abstracts, vol. 109(3): 22928e (1988).

Affiliated with

Also associated with

Rating

Tricyclic fused pryimidine derivatives, and their use as pharmac does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic fused pryimidine derivatives, and their use as pharmac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic fused pryimidine derivatives, and their use as pharmac will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1651206